These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 18856026)
1. [Registration of the first human vaccine against the highly pathogenic avian influenza A(H5N1) virus: considerations]. de Jong JC; Osterhaus AD Ned Tijdschr Geneeskd; 2008 Sep; 152(39):2113-5. PubMed ID: 18856026 [TBL] [Abstract][Full Text] [Related]
2. Development of a mucosal vaccine for influenza viruses: preparation for a potential influenza pandemic. Hasegawa H; Ichinohe T; Tamura S; Kurata T Expert Rev Vaccines; 2007 Apr; 6(2):193-201. PubMed ID: 17408369 [TBL] [Abstract][Full Text] [Related]
3. Immunogenicity, safety, and cross-reactivity of an inactivated, adjuvanted, prototype pandemic influenza (H5N1) vaccine: a phase II, double-blind, randomized trial. Wu J; Fang HH; Chen JT; Zhou JC; Feng ZJ; Li CG; Qiu YZ; Liu Y; Lu M; Liu LY; Dong SS; Gao Q; Zhang XM; Wang N; Yin WD; Dong XP Clin Infect Dis; 2009 Apr; 48(8):1087-95. PubMed ID: 19281330 [TBL] [Abstract][Full Text] [Related]
4. Strategies for developing vaccines against H5N1 influenza A viruses. Horimoto T; Kawaoka Y Trends Mol Med; 2006 Nov; 12(11):506-14. PubMed ID: 17011235 [TBL] [Abstract][Full Text] [Related]
5. Progress with human H5N1 vaccines: a perspective from industry. Palache B; Krause R Expert Rev Vaccines; 2009 Apr; 8(4):391-400. PubMed ID: 19348556 [TBL] [Abstract][Full Text] [Related]
6. NEW technologies for meeting the global demand for pandemic influenza vaccines. Fedson DS Biologicals; 2008 Nov; 36(6):346-9. PubMed ID: 18715803 [TBL] [Abstract][Full Text] [Related]
7. Pandemic H5N1 influenza vaccine development: an update. El Sahly HM; Keitel WA Expert Rev Vaccines; 2008 Mar; 7(2):241-7. PubMed ID: 18324892 [TBL] [Abstract][Full Text] [Related]
8. Preparing for a possible pandemic: influenza A/H5N1 vaccine development. Keitel WA; Atmar RL Curr Opin Pharmacol; 2007 Oct; 7(5):484-90. PubMed ID: 17644429 [TBL] [Abstract][Full Text] [Related]
9. Which factors are important in adults' uptake of a (pre)pandemic influenza vaccine? Zijtregtop EA; Wilschut J; Koelma N; Van Delden JJ; Stolk RP; Van Steenbergen J; Broer J; Wolters B; Postma MJ; Hak E Vaccine; 2009 Dec; 28(1):207-27. PubMed ID: 19800997 [TBL] [Abstract][Full Text] [Related]
10. An adjuvanted, low-dose, pandemic influenza A (H5N1) vaccine candidate is safe, immunogenic, and induces cross-reactive immune responses in healthy adults. Levie K; Leroux-Roels I; Hoppenbrouwers K; Kervyn AD; Vandermeulen C; Forgus S; Leroux-Roels G; Pichon S; Kusters I J Infect Dis; 2008 Sep; 198(5):642-9. PubMed ID: 18576945 [TBL] [Abstract][Full Text] [Related]
11. Prepandemic H5N1 influenza vaccine adjuvanted with AS03: a review of the pre-clinical and clinical data. Leroux-Roels G Expert Opin Biol Ther; 2009 Aug; 9(8):1057-71. PubMed ID: 19555313 [TBL] [Abstract][Full Text] [Related]
12. Current status and progress of prepandemic and pandemic influenza vaccine development. Leroux-Roels I; Leroux-Roels G Expert Rev Vaccines; 2009 Apr; 8(4):401-23. PubMed ID: 19348557 [TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children. Nolan T; Richmond PC; Formica NT; Höschler K; Skeljo MV; Stoney T; McVernon J; Hartel G; Sawlwin DC; Bennet J; Ryan D; Basser RL; Zambon MC Vaccine; 2008 Nov; 26(50):6383-91. PubMed ID: 18801398 [TBL] [Abstract][Full Text] [Related]
14. Pandemic influenza vaccine development: time is of the essence. Cox RJ; Brokstad KA; Haaheim LR Expert Rev Vaccines; 2006 Oct; 5(5):603-6. PubMed ID: 17181432 [No Abstract] [Full Text] [Related]
15. PolyI:polyC12U adjuvant-combined intranasal vaccine protects mice against highly pathogenic H5N1 influenza virus variants. Ichinohe T; Ainai A; Tashiro M; Sata T; Hasegawa H Vaccine; 2009 Oct; 27(45):6276-9. PubMed ID: 19840660 [TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of a prepandemic influenza A (H5N1) vaccine in children. Vajo Z; Kosa L; Szilvasy I; Pauliny Z; Bartha K; Visontay I; Kis A; Tarjan I; Rozsa N; Jankovics I Pediatr Infect Dis J; 2008 Dec; 27(12):1052-6. PubMed ID: 18978514 [TBL] [Abstract][Full Text] [Related]
17. Seasonal influenza vaccination may mitigate the potential impact of an H5N1 pandemic. Qin CF; Qin ED Chin Med J (Engl); 2008 Aug; 121(15):1481-3. PubMed ID: 18959131 [No Abstract] [Full Text] [Related]
18. [Pandemic and prepandemic H5N1 influenza vaccines: a 2009 update]. Loulergue P; Launay O Med Sci (Paris); 2009; 25(8-9):719-25. PubMed ID: 19765386 [TBL] [Abstract][Full Text] [Related]